XML 60 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2018
Stock-based Compensation Expense
The stock-based compensation related to all of our stock-based awards and employee stock purchases for the year ended December 31, 2018, 2017 and 2016 is as follows (in thousands):
 
For the Year Ended December 31,
 
2018
 
2017
 
2016
Cost of net revenues
$
3,695

 
$
3,330

 
$
3,966

Selling, general and administrative
56,422

 
46,550

 
42,612

Research and development
10,646

 
8,974

 
7,570

Total stock-based compensation
$
70,763

 
$
58,854

 
$
54,148

Stock Option Activity
Activity for the year ended December 31, 2018, under the stock option plans is set forth below: 
 
Number of
Shares
Underlying
Stock Options
(in thousands)
 
Weighted
Average
Exercise
Price per Share
 
Weighted Average
Remaining
Contractual Term
(in years)
 
Aggregate
Intrinsic
Value
(in thousands)
Outstanding as of December 31, 2017
75

 
$
11.36

 
 
 
 
Exercised
(67
)
 
11.76

 
 
 
 
Cancelled or expired

 

 
 
 
 
Outstanding as of December 31, 2018
8

 
$
8.07

 
0.16
 
$
1,649

Vested at December 31, 2018
8

 
$
8.07

 
0.16
 
$
1,649

Exercisable at December 31, 2018
8

 
$
8.07

 
0.16
 
$
1,649

Fair value assumptions using the Monte Carlo simulation
The following weighted-average assumptions used in the Monte Carlo simulation were as follows: 
 
Year Ended December 31,
 
2018
 
2017
 
2016
Expected term (in years)
3.0

 
3.0

 
3.0

Expected volatility
31.9
%
 
28.9
%
 
34.0
%
Risk-free interest rate
2.5
%
 
1.5
%
 
0.9
%
Expected dividends

 

 

Weighted average fair value per share at grant date
$
470.75

 
$
120.39

 
$
68.88

Schedule of ESPP share activity
The following table summarizes the ESPP shares issued:
 
Year Ended December 31,
 
2018
 
2017
 
2016
Number of shares issued (in thousands)
164

 
202

 
197

Weighted average price
$
96.95

 
$
59.93

 
$
48.65

Employee Stock Purchase Plan 2010  
Weighted Average Assumptions Used for the Fair Value of Options Component of Purchase Plan Granted Estimated at Grant Date
The fair value of the option component of the 2010 Purchase Plan shares was estimated at the grant date using the Black-Scholes option pricing model with the following weighted average assumptions:
 
Year Ended December 31,
  
2018
 
2017
 
2016
Expected term (in years)
1.3

 
1.2

 
1.2

Expected volatility
35.2
%
 
26.8
%
 
30.5
%
Risk-free interest rate
2.2
%
 
1.0
%
 
0.7
%
Expected dividends

 

 

Weighted average fair value at grant date
$
94.71

 
$
31.36

 
$
22.23

Stock Option  
Weighted Average Assumptions Used for the Fair Value of Options Component of Purchase Plan Granted Estimated at Grant Date
Activity for the year ended December 31, 2018, under the stock option plans is set forth below: 
 
Number of
Shares
Underlying
Stock Options
(in thousands)
 
Weighted
Average
Exercise
Price per Share
 
Weighted Average
Remaining
Contractual Term
(in years)
 
Aggregate
Intrinsic
Value
(in thousands)
Outstanding as of December 31, 2017
75

 
$
11.36

 
 
 
 
Exercised
(67
)
 
11.76

 
 
 
 
Cancelled or expired

 

 
 
 
 
Outstanding as of December 31, 2018
8

 
$
8.07

 
0.16
 
$
1,649

Vested at December 31, 2018
8

 
$
8.07

 
0.16
 
$
1,649

Exercisable at December 31, 2018
8

 
$
8.07

 
0.16
 
$
1,649

Restricted Stock Units (RSUs)  
Summary of Nonvested Shares
A summary for the year ended December 31, 2018, is as follows:
 
Number of Shares
Underlying  RSUs
(in thousands)
 
Weighted Average Grant Date Fair Value
 
Weighted Average
Remaining
Contractual Term
(in years)
 
Aggregate
Intrinsic Value
(in thousands)
Nonvested as of December 31, 2017
1,341

 
$
82.30

 
 
 
 
Granted
235

 
262.58

 
 
 
 
Vested and released
(562
)
 
75.22

 
 
 
 
Forfeited
(83
)
 
112.33

 
 
 
 
Nonvested as of December 31, 2018
931

 
$
129.42

 
1.04
 
$
194,950

Market Performance Based Restricted Stock Units  
Summary of Nonvested Shares
The following table summarizes the MSU performance for the year ended December 31, 2018:
 
Number of Shares
Underlying MSUs
(in thousands)
 
Weighted Average Grant Date Fair Value
 
Weighted Average
Remaining
Contractual Term
(in years)
 
Aggregate
Intrinsic Value
(in thousands)
Nonvested as of December 31, 2017
428

 
$
78.53

 
 
 


Granted
208

 
266.78

 
 
 
 
Vested and released
(312
)
 
62.41

 
 
 
 
Forfeited

 

 
 
 
 
Nonvested as of December 31, 2018
324

 
$
215.07

 
1.16
 
$
67,897